C12N 2770/24163
By chemical treatment
Official title: by chemical treatment
C12N2770/24163 (By chemical treatment) appears on 48 US grants and 63 published applications in this corpus.
Search patents in C12N- Granted patents
- 48
- Published applications
- 63
- Assignees
- 32
- Inventors
- 93
- Latest grant
- 23 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 1 | 2 |
| 2006 | 0 | 1 |
| 2007 | 1 | 4 |
| 2008 | 1 | 1 |
| 2009 | 1 | 2 |
| 2010 | 2 | 1 |
| 2011 | 1 | 2 |
| 2012 | 1 | 1 |
| 2013 | 0 | 1 |
| 2014 | 2 | 1 |
| 2015 | 1 | 3 |
| 2016 | 0 | 3 |
| 2017 | 2 | 1 |
| 2018 | 1 | 5 |
| 2019 | 3 | 3 |
| 2020 | 5 | 7 |
| 2021 | 2 | 6 |
| 2022 | 6 | 4 |
| 2023 | 4 | 7 |
| 2024 | 7 | 5 |
| 2025 | 3 | 3 |
By publication year. Applications have been published since 2001.
Recent patents
- Inorganic polyatomic oxyanions for protecting against antigenic damage during pathogen inactivation for vaccine production23 Sep 2025US 12,419,947 B2Najit Technologies, Inc.
- Virus purification and formulation process20 May 2025US 12,305,198 B2Global Life Sciences Solutions USA LLC
- Virus purification4 Feb 2025US 12,214,033 B2Valneva SE
- Zika vaccines and immunogenic compositions, and methods of using the same8 Oct 2024US 12,109,260 B2Takeda Vaccines, Inc.
- Zika virus vaccine1 Oct 2024US 12,102,673 B2Valneva Austria GmbH
- Zika vaccines and immunogenic compositions, and methods of using the same18 Dec 2025US 2025/0381261 A1Takeda Vaccines, Inc.
- Thermostable uv inactivated vaccines and other biopharmaceuticals5 Jun 2025US 2025/0177534 A1Universal Stabilization Technologies, Inc.
- Zika Virus Vaccine16 Jan 2025US 2025/0018023 A1Valneva Austria GmbH
- Method for inactivating zika virus and for determining the completeness of inactivation3 Oct 2024US 2024/0325518 A1Takeda Vaccines, Inc.
- Zika vaccines and immunogenic compositions, and methods of using the same29 Aug 2024US 2024/0285747 A1Takeda Vaccines, Inc.
Most cited
By later US patents
- Method for inactivating a virus36US 5,891,705 APentose Pharmaceuticals, Inc. · 1999
- Method of inactivating lipid-enveloped viruses32US 6,136,321 ABaxter Aktiengesellschaft · 2000
- Method and kit for detection of dengue virus26US 6,190,859 B1The United States of America as represented by the Secretary of the Army · 2001
- Virus purification14US 10,537,630 B2Valneva SE · 2020
- Vaccines against West Nile Virus14US 7,425,437 B2Crucell Holland B. V. · 2008